BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines non-GAAP Adjusted Research & Development Expense ($M) ($M)
Form 8-K EX-99.1 Non-GAAP Reconciliation Tables
Latest, Q2 2026
534
Period ended Jun 30, 2026
Change on a year earlier
+20.2%
444 in Q2 2025
History
15 quarters
Since Q4 2022
Sources
11
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adjusted Research & Development Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 534 | +20.2% | Form 8-K (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 466 | +10.6% | Form 8-K (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 545 | +14.7% | Form 8-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 446 | +10.0% | Form 8-K (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 444 | +16.1% | Form 8-K (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 421 | +3.9% | Form 8-K (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 475 | +8.6% | Form 8-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 30, 2024 | 406 | +2.4% | Form 8-K (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 383 | +5.2% | Form 8-K (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 405 | +12.1% | Form 8-K (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 437 | +8.2% | Form 8-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 396 | – | Form 8-K (filed 2024-11-12) ↗ |
| Q2 2023 | Jun 30, 2023 | 364 | – | Form 8-K (filed 2024-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 362 | – | Form 8-K (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 404 | – | Form 8-K (filed 2024-02-26) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Non-GAAP Adjusted Research & Development Expense ($M) ($M), quarterly Q4 2022–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj_rd_exp
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.